Drug safety tested in people with weakened kidneys
NCT ID NCT07137689
Summary
This study aims to understand how a new drug, LY3537982, is processed by the body in people with reduced kidney function. It will compare drug levels in 32 participants with moderate or severe kidney impairment to those with normal kidney function. The goal is to gather information to help determine safe and effective doses for future patients with kidney problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genesis Clinical Research
RECRUITINGTampa, Florida, 33603, United States
-
Jacksonville Center for Clinical Research
RECRUITINGJacksonville, Florida, 32216, United States
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.